The ability to be a reliable historian and judge of any changes after exosome therapy is a challenge for nearly everyone.
Facebook is where discourse goes to die and everyone merely echoes the poster’s premise
In this lively interview I conducted with Michael Rose, professor of evolutionary biology at the University of California, Irvine, we delve into some pretty heady topics
The problem of a randomized controlled trial is that it doesn’t explain mechanism or pertain to individual subjects
DISCLAIMER: This website is for educational purposes only and is not for advertising. Telomerase activators and nanovesicles are not FDA-approved to prevent or treat any disease and anecdotes are not scientific proof of efficacy. All patients were treated in the context of a fully informed and legally-protected patient physician relationship.
Required fields
© 2020 Recharge Biomedical
Exosomes and TA-65 are not FDA-approved to prevent or treat any illness
